WHO ICTRP trial
The Effect and safety of Botox in the treatment of patients with Spinal injury…
RBR-67ynvt · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-67ynvt |
|---|---|
| Public title | The Effect and safety of Botox in the treatment of patients with Spinal injury associated with Human T-cell Lymphotrofic Virus type I |
| Scientific title | Efficacy and safety of Botulinum Toxin in the treatment of spasticity in patients with Tropical spastic paraparesis |
| Primary sponsor | Hospital Universitário Professor Edgard Santos |
| Secondary sponsors | Hospital Universitário Professor Edgard Santos |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | Human T lymphotropic virus 1; tropical spastic paraparesis;B04.613.807.200.725.400;C02.782.815.200.470.710 |
| Interventions | 40 individuals will be recruited. All research participants will be treated with physiotherapy and will receive baclofen tablets (daily use of 3 10mg tablets for three months). They will be divided into two groups: the experimental group… |
| Registration date | Feb 20, 2020 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: